Back

Notification report


Full notification file


General information

Notification Number
B/DE/15/PEI2425

Member State to which the notification was sent
Germany

Date of acknowledgement from the Member State Competent Authority
22/05/2015

Title of the Project
Clinical Trial:
Treatment of Advanced Gastrointestinal Adenocarcinoma in a Phase I/II trial with modified allogeneic MSC_apceth_111


Proposed period of release:
01/10/2015 to 31/12/2016

Name of the Institute(s) or Company(ies)
apceth GmbH & Co.KG, ;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMO been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
Other: mammal

Identity of the GMO:
Identity of the GMO (genus and species)
genus: homo
species: sapiens
Genetically modified mesenchymal stem cells (somatic cells) derived from Homo sapiens.


Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Mesenchymal stem cell derived from humansHomoSapiens---

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
05/11/2015 00:00:00
Remarks: